Biosurfactant from Bacillus sp. A5F Reduces Disease Incidence of Sclerotinia sclerotiorum in Soybean Crop.

Curr Microbiol

Former NASI Senior Scientist, LV-32, Indus Garden, Bhopal, M.P., 462039, India.

Published: May 2022

The present study was conducted to assess the biocontrol activity of biosurfactants obtained from Bacillus species A5F. The variables significantly influencing the production of biosurfactants under in vitro conditions were further optimized using response surface methodology. Optimal values of selected culture variables, i.e., glucose, soybean oil, and incubation time were 3.5 g l, 3.5 ml l, and 78 h, respectively, resulting in 2.14-fold enhancement in biosurfactant levels in 5 l fermentor. Identified biosurfactants had a significant effect on chlorophyll content, shoot biomass, number of pods, and seed weight. Biosurfactants also reduced the disease incidence in S. sclerotiorum infected soybean plants and showed antagonistic action against major phytopathogens by disrupting the hyphal cell wall. 16% reduction in ITS gene copy number was observed as compared to control with less non-target effect upon biosurfactant spray on foliar parts of soybean. Thus, the study confirms that biosurfactants from strain A5F can be used as a potent biocontrol agent to control sclerotium wilt on soybean plants.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00284-022-02897-3DOI Listing

Publication Analysis

Top Keywords

disease incidence
8
soybean plants
8
soybean
5
biosurfactants
5
biosurfactant bacillus
4
bacillus a5f
4
a5f reduces
4
reduces disease
4
incidence sclerotinia
4
sclerotinia sclerotiorum
4

Similar Publications

An updated systematic review with meta-analysis and meta-regression of the factors associated with human visceral leishmaniasis in the Americas.

Infect Dis Poverty

January 2025

Universidade Federal de São João del Rei (UFSJ), Campus Centro-Oeste Dona Lindu, Avenida Sebastião Gonçalves Coelho 400, Chanadour, Divinópolis, MG, Brazil.

Background: Human visceral leishmaniasis (VL) is a systemic disease with high case-fatality rates and a widespread distribution. Continuous evaluation of the risk factors for VL is essential to ensure the effective implementation of prevention and control measures. The present study reviews the factors associated with VL in the Americas.

View Article and Find Full Text PDF

Background: Esophageal and gastric cancer were among the top 10 most common cancers worldwide. In addition, sex-specific differences were observed in the incidence. Due to their anatomic proximity, the 2 cancers have both different but also shared risk factors and epidemiological features.

View Article and Find Full Text PDF

Background: This study evaluated Health Care Workers' (HCWs) knowledge, attitude, perceived compliance, and potential influencing factors related to Infection Prevention and Control (IPC) standards in the North Bank East region of The Gambia.

Method: The study was an analytic cross-sectional study, conducted in 2021 using a multistage sampling technique. Thirteen health facilities were sampled from the North Bank East Region of The Gambia.

View Article and Find Full Text PDF

Healthcare performance of leprosy management in peripheral health facilities of Dhanusa and Mahottari, Nepal.

BMC Health Serv Res

January 2025

Department of Health Services, Epidemiology and Disease Control Division, Ministry of Health and Population, Kathmandu, Nepal.

Background: The global elimination of leprosy transmission by 2030 is a World Health Organization (WHO) target. Nepal's leprosy elimination program depends on early case diagnosis and the performance of health workers and facilities. The knowledge and skills of paramedical staff (Leprosy Focal Person, LFP) and case documentation and management by health facilities are therefore key to the performance of health care services.

View Article and Find Full Text PDF

Background: PARP inhibitors (PARPis) have shown promising effectiveness for ovarian cancer. This network meta-analysis (PROSPERO registration number CRD42024503390) comprehensively evaluated the effectiveness and safety of PARPis in platinum-sensitive recurrent ovarian cancer (PSROC).

Methods: Articles published before January 6, 2024 were obtained from electronic databases.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!